Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Common Equity (2016 - 2025)

Historic Common Equity for Lemaitre Vascular (LMAT) over the last 17 years, with Q3 2025 value amounting to $378.9 million.

  • Lemaitre Vascular's Common Equity rose 1445.27% to $378.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $378.9 million, marking a year-over-year increase of 1445.27%. This contributed to the annual value of $337.3 million for FY2024, which is 1322.26% up from last year.
  • Lemaitre Vascular's Common Equity amounted to $378.9 million in Q3 2025, which was up 1445.27% from $362.7 million recorded in Q2 2025.
  • Lemaitre Vascular's 5-year Common Equity high stood at $378.9 million for Q3 2025, and its period low was $177.5 million during Q1 2021.
  • In the last 5 years, Lemaitre Vascular's Common Equity had a median value of $283.8 million in 2023 and averaged $286.4 million.
  • In the last 5 years, Lemaitre Vascular's Common Equity soared by 5470.45% in 2021 and then soared by 489.83% in 2022.
  • Lemaitre Vascular's Common Equity (Quarter) stood at $254.2 million in 2021, then grew by 5.53% to $268.2 million in 2022, then increased by 11.07% to $297.9 million in 2023, then rose by 13.22% to $337.3 million in 2024, then rose by 12.34% to $378.9 million in 2025.
  • Its Common Equity stands at $378.9 million for Q3 2025, versus $362.7 million for Q2 2025 and $347.6 million for Q1 2025.